Moreover, inhibiting blood vessel growth using a VEGFR inhibitor prevented the recovery of the survival rate of tumor cells in the later stage, demonstrating the critical role of angiogenesis in acquired drug resistance. This evidence concerns the gene KDR and neoplasm.